Human diversity in killer cell inhibitory receptor genes.
暂无分享,去创建一个
P Parham | P. Parham | L. Lanier | M. Uhrberg | N. Valiante | L L Lanier | D. Tyan | N M Valiante | M Uhrberg | B P Shum | H G Shilling | K Lienert-Weidenbach | B Corliss | D Tyan | B. Corliss | H. Shilling | B. Shum | K. Lienert-Weidenbach
[1] P Parham,et al. Functionally and structurally distinct NK cell receptor repertoires in the peripheral blood of two human donors. , 1997, Immunity.
[2] Eric O Long,et al. A new human gene complex encoding the killer cell inhibitory receptors and related monocyte/macrophage receptors , 1997, Current Biology.
[3] Nallasivam Palanisamy,et al. Genomic organization and allelic polymorphism of the human killer cell inhibitory receptor gene KIR 103 , 1997 .
[4] J. Trowsdale,et al. Genomic organization of a human killer cell inhibitory receptor gene. , 1997, Tissue antigens.
[5] L. Lanier,et al. Natural killer cell cytolytic activity is inhibited by NKG2-A and activated by NKG2-C. , 1997, Journal of immunology.
[6] Andrew G. Brooks,et al. NKG2A Complexed with CD94 Defines a Novel Inhibitory Natural Killer Cell Receptor , 1997, The Journal of experimental medicine.
[7] P. Parham,et al. Killer cell receptors: keeping pace with MHC class I evolution , 1997, Immunological reviews.
[8] M. Carretero,et al. The CD94 and NKG2‐A C‐type lectins covalently assemble to form a natural killer cell inhibitory receptor for HLA class I molecules , 1997, European journal of immunology.
[9] L. Lanier,et al. Arousal and inhibition of human NK cells , 1997, Immunological reviews.
[10] L. Lanier,et al. Human natural killer cell receptors involved in MHC class I recognition are disulfide-linked heterodimers of CD94 and NKG2 subunits. , 1996, Journal of immunology.
[11] B Dupont,et al. NK cell receptor gene of the KIR family with two IG domains but highest homology to KIR receptors with three IG domains. , 1996, Tissue antigens.
[12] P. Parham,et al. CD94 and a novel associated protein (94AP) form a NK cell receptor involved in the recognition of HLA-A, HLA-B, and HLA-C allotypes. , 1996, Immunity.
[13] R. Biassoni,et al. The natural killer cell receptor specific for HLA-A allotypes: a novel member of the p58/p70 family of inhibitory receptors that is characterized by three immunoglobulin-like domains and is expressed as a 140-kD disulphide-linked dimer , 1996, The Journal of experimental medicine.
[14] M. Colonna,et al. A human killer inhibitory receptor specific for HLA-A1,2. , 1996, Journal of immunology.
[15] P. Parham,et al. Unexpected beta2-microglobulin sequence diversity in individual rainbow trout. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[16] P. Parham,et al. Heterogeneous phenotypes of expression of the NKB1 natural killer cell class I receptor among individuals of different human histocompatibility leukocyte antigens types appear genetically regulated, but not linked to major histocompatibililty complex haplotype , 1996, The Journal of experimental medicine.
[17] Eric O Long,et al. Inhibitory MHC class I receptors on NK and T cells: a standard nomenclature. , 1996, Immunology today.
[18] L. Lanier,et al. Inhibitory MHC class I receptors on NK cells and T cells. , 1996, Immunology today.
[19] R. Biassoni,et al. The human leukocyte antigen (HLA)-C-specific "activatory" or "inhibitory" natural killer cell receptors display highly homologous extracellular domains but differ in their transmembrane and intracytoplasmic portions , 1996, The Journal of experimental medicine.
[20] Eric O Long,et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. , 1996, Immunity.
[21] T. Mcclanahan,et al. Molecular cloning of NKB1. A natural killer cell receptor for HLA-B allotypes. , 1995, Journal of immunology.
[22] L. Lanier,et al. Molecular characterization of human CD94: A type II membrane glycoprotein related to the C‐type lectin superfamily , 1995, European journal of immunology.
[23] L. Moretta,et al. Existence of both inhibitory (p58) and activatory (p50) receptors for HLA-C molecules in human natural killer cells , 1995, The Journal of experimental medicine.
[24] P. Parham,et al. Amino acid substitutions can influence the natural killer (NK)-mediated recognition of HLA-C molecules. Role of serine-77 and lysine-80 in the target cell protection from lysis mediated by "group 2" or "group 1" NK clones , 1995, The Journal of experimental medicine.
[25] Eric O Long,et al. Molecular clones of the p58 NK cell receptor reveal immunoglobulin-related molecules with diversity in both the extra- and intracellular domains. , 1995, Immunity.
[26] M. Colonna,et al. Cloning of immunoglobulin-superfamily members associated with HLA-C and HLA-B recognition by human natural killer cells. , 1995, Science.
[27] P. Parham,et al. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor , 1995, The Journal of experimental medicine.
[28] E. Adams,et al. The Origins of HLA‐A,B,C Polymorphism , 1995, Immunological reviews.
[29] P. Parham. The rise and fall of great class I genes. , 1994, Seminars in immunology.
[30] M. López-Botet,et al. Human natural killer cell receptors for HLA-class I molecules. Evidence that the Kp43 (CD94) molecule functions as receptor for HLA-B alleles , 1994, The Journal of experimental medicine.
[31] P. Parham,et al. NKB1: a natural killer cell receptor involved in the recognition of polymorphic HLA-B molecules , 1994, The Journal of experimental medicine.
[32] M. Balboa,et al. Tyrosine kinase-dependent activation of human NK cell functions upon stimulation through a 58-kDa surface antigen selectively expressed on discrete subsets of NK cells and T lymphocytes. , 1994, Journal of immunology.
[33] P. Parham,et al. Structural heterogeneity in HLA-B70, a high-frequency antigen of black populations. , 1993, Tissue antigens.
[34] P. Parham,et al. Specificity of HLA class I antigen recognition by human NK clones: evidence for clonal heterogeneity, protection by self and non-self alleles, and influence of the target cell type , 1993, The Journal of experimental medicine.
[35] E. Ciccone,et al. P58 molecules as putative receptors for major histocompatibility complex (MHC) class I molecules in human natural killer (NK) cells. Anti-p58 antibodies reconstitute lysis of MHC class I-protected cells in NK clones displaying different specificities , 1993, The Journal of experimental medicine.
[36] E. Brooks,et al. Generation of allospecific natural killer cells by stimulation across a polymorphism of HLA-C. , 1993, Science.
[37] W. Yokoyama. Recognition structures on natural killer cells. , 1993, Current opinion in immunology.
[38] A. Amoroso,et al. Involvement of HLA class I alleles in natural killer (NK) cell-specific functions: expression of HLA-Cw3 confers selective protection from lysis by alloreactive NK clones displaying a defined specificity (specificity 2) , 1992, The Journal of experimental medicine.
[39] J. Strominger,et al. Alloantigen recognition by two human natural killer cell clones is associated with HLA-C or a closely linked gene. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[40] W. Yokoyama,et al. MHC class I alloantigen specificity of Ly-49+ IL-2-activated natural killer cells , 1992, Nature.
[41] F. Bach,et al. DNA sequence analysis of NKG2, a family of related cDNA clones encoding type II integral membrane proteins on human natural killer cells , 1991, The Journal of experimental medicine.
[42] H. Ljunggren,et al. In search of the 'missing self': MHC molecules and NK cell recognition. , 1990, Immunology today.
[43] P. Cresswell,et al. NK susceptibility varies inversely with target cell class I HLA antigen expression. , 1987, Journal of immunology.
[44] H. Ljunggren,et al. Selective rejection of H–2-deficient lymphoma variants suggests alternative immune defence strategy , 1986, Nature.
[45] W. V. van Blitterswijk,et al. Serum-free medium for generation and propagation of functional human cytotoxic and helper T cell clones. , 1984, Journal of immunological methods.